Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)CHEVALLIER, P; LABOPIN, M; BAY, J.-O et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 3, pp 361-365, issn 0268-3369, 5 p.Article

Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipientsMORFIN, F; SOUILLET, G; BILGER, K et al.The Journal of infectious diseases. 2000, Vol 182, Num 1, pp 290-293, issn 0022-1899Article

Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-αMICHALLET, M; THIEBAUT, A; SALLES, B et al.Leukemia. 2000, Vol 14, Num 12, pp 2064-2069, issn 0887-6924Article

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)CAHU, X; CHEVALLIER, P; ROBIN, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 6, pp 756-760, issn 0268-3369, 5 p.Article

Rituximab dans le traitement de syndrome lymphoprolifératif après allogreffe de cellules souches hématopoïétiques = Rituximab in the management of lymphoproliferative disorders after allograft stem cell transplantationSANTUCCI, R; LEVEQUE, D; FOHRER, C et al.Journal de pharmacie clinique (Paris). 2009, Vol 28, Num 3, pp 127-133, issn 0291-1981, 7 p.Article

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationMOHTY, M; BILGER, K; BORDIGONI, P et al.Leukemia. 2003, Vol 17, Num 5, pp 869-875, issn 0887-6924, 7 p.Article

Conduite à tenir devant un problème du donneur de cellules souches hématopoïétiques: test de grossesse positif et gammapathie monoclonale = How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: An SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathyDULERY, R; GIRAUD, C; DEWILDE, A et al.Pathologie et biologie. 2013, Vol 61, Num 4, pp 158-159, issn 0369-8114, 2 p.Article

Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMTBORIES, P; ZINK, E; MATTERN, J. F et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 2, pp 301-303, issn 0268-3369, 3 p.Article

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationIVANOV, V; FAUCHER, C; BOUABDALLAH, R et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 10, pp 901-906, issn 0268-3369, 6 p.Article

Conduite à tenir devant une anomalie biologique découverte lors du bilan pré-don cellules souches hématopoïétiques: sérologie IgM positive pour le cytomégalovirus, le virus d'Epstein-Barr, la toxoplasmose, ou la syphilis = How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: An SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology testDULERY, R; GIRAUD, C; DEWILDE, A et al.Pathologie et biologie. 2013, Vol 61, Num 4, pp 155-157, issn 0369-8114, 3 p.Article

Survenue d'une thrombopénie sévère et durable, au décours d'une greffe de moelle allogénique, imputable à l'existence chez l'hôte d'une allo-immunisation anti-HPA-1 = Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1 allo-immunisation of the hostPARISSIADIS, A; BILGER, K; LAPLACE, A et al.Transfusion clinique et biologique (Paris). 2010, Vol 17, Num 4, pp 265-268, issn 1246-7820, 4 p.Article

Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimenMOHTY, M; MOHTY, A. M; GAUGLER, B et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 839-846, issn 0268-3369, 8 p.Article

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb levelIVANOV, V; FAUCHER, C; BOUABDALLAH, R et al.Transfusion (Philadelphia, PA). 2004, Vol 44, Num 4, pp 501-508, issn 0041-1132, 8 p.Article

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationMOHTY, M; BOIRON, J. M; TABRIZI, R et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 1, pp 77-84, issn 0268-3369, 8 p.Article

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationMOHTY, M; DE LAVALLADE, H; BLAISE, D et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 6, pp 527-530, issn 0268-3369, 4 p.Article

Intérêt de la détection d'antigène aspergillaire dans le liquide céphalo-rachidien en cas de suspicion d'aspergillose cérébrale = Detection of Aspergillus antigen in cerebrospinal fluid in the diagnosis of cerebral aspergillosisPIENS, M.-A; THIEBAUT, A; BILGER, K et al.Journal de mycologie médicale (Paris). 2004, Vol 14, Num 1, pp 28-33, issn 1156-5233, 6 p.Article

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenMOHTY, M; JACOT, W; STOPPA, A. M et al.Leukemia. 2003, Vol 17, Num 11, pp 2168-2177, issn 0887-6924, 10 p.Article

Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [¹⁸F]fluoride ion positron emission tomographyPIERT, M; WINTER, E; BECKER, G. A et al.European journal of nuclear medicine. 1999, Vol 26, Num 6, pp 615-624, issn 0340-6997Article